Rare artery disease linked to higher heart attack and stroke risk

NCT ID NCT07686991

Completed Knowledge-focused Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil Source: ClinicalTrials.gov ↗

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study uses French national health data to compare the risk of major heart problems—like heart attack, stroke, and death—in people with Takayasu arteritis versus similar people without the disease. It also looks at how steroid use may affect these risks. The goal is to better understand and manage cardiovascular complications in this rare inflammatory condition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If it works, this could help doctors better predict and prevent heart problems in people with Takayasu arteritis.
What could go wrong: This is an observational study using existing data, so it cannot prove cause and effect. Results may not apply to other countries or populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atherosclerosis cardiovascular disorder Inflammation Takayasu arteritis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CARDIOVASCULAR DISEASES TAKAYASU ARTERITIS

Contacts and locations

Show contact details

Locations

APHP_ Hôpital Pitié-Salpêtrière

Paris, France
APHP_ Hôpital Saint-Antoine

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.